Guess which ASX small-cap stock exploded 154% on big US news!

ASX small-cap stocks carry added risk, but also sometimes offer supersized rewards.

| More on:
A little girl with red hair runs excitedly with a rocket strapped to her back, trying to launch.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The All Ordinaries Index (ASX: XAO) is up a healthy 1.0% on Wednesday, but one ASX small-cap stock is leaving those gains wanting.

The company in question is Bio-Gene Technology Ltd (ASX: BGT), which is focused on developing bio-insecticides to combat insecticide resistance and toxicity issues around the world.

Shares in the ASX small-cap stock closed yesterday at 2.8 cents. In earlier trade, they were trading for 7.1 cents, up an eye-watering 153.6%. At the time of writing, shares are changing hands for 6.8 cents apiece, up 142.9%.

Or enough to turn a $5,000 investment yesterday into $12,145 today.

Boom!

Here's what's grabbing investor interest.

ASX small-cap stock rockets on US grants

The Bio-Gene share price is going through the roof after the company reported on two new grant awards.

The grants from the United States Department of Defense (DoD) Deployed Warfighter Protection (DWFP) program total $3.0 million. The ASX small-cap stock said it is not required to match these funding commitments.

The DWFP program, administered by the US Armed Forces Pest Management Board, supports research and development of novel technologies to protect US military personnel from threats posed by disease-carrying insect pests.

Bio-Gene said the first grant of $1.6 million will see it develop a wearable product containing Flavocide to control mosquitoes and other insect vectors of disease.

The second grant of $1.4 million will see the ASX small-cap company develop a sprayable formulation of Qcide to provide residual control of flies and bed bug infestations.

Bio-Gene is developing Flavocide and Qcide as new insecticides derived from nature for use in public health, crop protection, grain storage and consumer applications.

"This funding will support the development of innovative products containing Flavocide and Qcide specifically designed for the defence and civilian markets," Bio-Gene CEO Tim Grogan said. "These new product opportunities are directly aligned with our commercial development programs for both Flavocide and Qcide."

Grogan added:

The award of these grants involved a peer-reviewed, highly competitive process and provides substantial validation for the potential for both Flavocide and Qcide to provide new solutions for pest control.

And the ASX small-cap stock could potentially tap into a much larger market.

According to Grogan:

In addition to military use, we see a very large commercial opportunity for these products in the civilian market, where more than 700,000 deaths occur annually from vector-borne diseases, and the market for products to eradicate bed bugs is projected to increase from US$2.3 billion in 2023 to US$4.9 billion by 2032.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Small Cap Shares

A female ASX investor looks through a magnifying glass that enlarges her eye and holds her hand to her face with her mouth open as if looking at something of great interest or surprise.
Small Cap Shares

2 under-$5 ASX hidden gems worth your attention

These buy-rated shares are flying under the radar. Let's see why analysts are bullish on them.

Read more »

Miner looking at a tablet.
Resources Shares

2 small-cap ASX mining shares exploding 40%+ on China tariff news

Investors are sending the small-cap ASX mining shares flying higher on Wednesday.

Read more »

Siblings jumping on a trampoline.
Small Cap Shares

3 ASX small-cap shares with a 'solid growth outlook' for 2025

A leading fund manager expects strong growth from these ASX small-cap stocks in 2025.

Read more »

A group of businesspeople clapping.
Healthcare Shares

This fund returned 109% in 2024. Here are 2 of its best-performing ASX shares

Small caps proved to be the winners last year.

Read more »

A boy stands firm on a rocky cliff holding a rocket in each hand and looking up toward the sky, anticipating flying into space.
Technology Shares

2 small-cap ASX tech shares rocketing on big US news

The junior ASX tech shares are enjoying a big lift following positive developments in the US.

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Small Cap Shares

Guess which ASX small-cap is up 92% in just 2 days!

Investors have been fighting to get hold of this stock this week. But why?

Read more »

Two boys looking at each other while standing by start line on stadium against two schoolgirls.
Small Cap Shares

The imminent tailwind for ASX small-cap shares: fundie

Oscar Oberg from Wilson Asset Management explains why he thinks it's a good time to buy small-caps.

Read more »

Small girl giving a fist bump with a piggy bank in front of her.
Small Cap Shares

Want more exposure to small-cap stocks? I'd invest in this ASX ETF

Small-caps can have a lot of growth potential.

Read more »